DOD and HHS Invest $24.3M in Becton, Dickinson and Company to Establish and Expand Production of SARS-CoV-2 Assays for BD Veritor™ Devices

IMMEDIATE RELEASE DOD and HHS Invest $24.3M in Becton, Dickinson and Company to Establish and Expand Production of SARS-CoV-2 Assays for BD Veritor™ Devices July 31, 2020 As part of an ongoing collaboration between the Department of Health and Human Services and the Department of Defense, the two departments awarded a contract for $24.3 million to Becton, Dickinson and Company (BD) to establish and expand domestic production of SARS-CoV-2 rapid point-of-care tests. Read More

NEWSROOM PRODUCTS

OUR STORY   KNOW YOUR MILITARY   ASK US   LATEST STORIES

Unsubscribe | Contact Us

This email was sent to stevenmagallanes520.nims@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Department of Defense 1400 Defense Pentagon Washington, DC 20301-1400